Ultraviolet light-induced keratinocyte apoptosis: A potential mechanism for the induction of skin lesions and autoantibody production in LE

Lupus

Volumn 6, Issue 2, 1997, Pages 175-180

  Casciola Rosen, L ^a   Rosen, A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autoantibody; ICE; Keratinocytes; Lupus

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; KERATINOCYTE; PERIODICITY; PLEIOTROPY; PRIORITY JOURNAL; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0031046862     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600213     Document Type: Article

References (52)

1. Pistiner M et al. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthitis Rheum 1991; 21: 55-64.
2. Stevens MB. Systemic lupus erythematosus clinical issues. Springer Semin Immunopathol 1986; 9: 251-270.
3. Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Ann Rev Immunol 1994, 12: 487-520.
4. Diamond et al. The role of somatic mutation in the pathogenic anti-DNA response. Ann Rev Immunol 1992; 10: 731-757.
5. Sercarz EE et al. Dominance and crypticity of T cell antigenic determinants. Ann Rev Immunol 1993; 11: 729-766.
6. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med 1995; 181: 1945-1948.
7. Gammon G, Sercarz EE. How some T cells escape tolerance induction. Nature 1989; 342: 183-185.
8. Mamula MJ. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J Exp Med 1993; 177: 567-571.
9. Bockenstedt LK, Gee RJ, Mamula MJ. Self-peptides in the initiation of lupus autoimmunity. J Immunol 154; 154: 3516-3524.
10. Salemi et al. HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J Exp Med 1995; 181: 2253-2257.
11. Watts C, Lanzavecchia A. Suppressive effect of an antibody on processing of T ce1l epitopes. J Exp Med 1993; 178: 1459-1463.
12. Simitsek PD et al. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995; 181: 1957-1963.
13. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995; 182: 1625-1634.
14. Natali PG, Tan EM. Experimental skin lesions in mice resembling systemic lupus erythematosus. Arthritis Rheum 1973; 16: 579-589.
15. LeFeber WP et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 1984; 74: 1545-1551.
16. Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA. Binding of antibodies to the extractable nuclear antigens of SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 1990; 94: 77-85.
17. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992; 90: 1067-1076.
18. Provost YT. The lupus band test. Int J Dermatol 1981; 20: 475-481.
19. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330.
20. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
21. Casciola-Rosen LA, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in SLE. Proc Natl Acad Sci USA 1996; 93: 1624-1629.
22. Martin SJ, Green DR. Protease activation during apoptosis: Death by a thousand cuts?. Cell 1995; 82: 349-352.
23. Chinnaiyan AM, Dixit VM. The cell-death machine. Curr Biol 1996; 6: 555-562.
24. Kumar S. ICE-like proteases in apoptosis. Trends Biochem Sci 1995; 20: 198-202.
25. Yuan et al. The C. elegans cell death gene ced-3 encodes a protein similar to the mammalian interleukin-1 β-converting enzyme. Cell 1993; 75: 641-652.
26. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 1996; 85: 803-815.
27. Muzio M et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817-827.
28. Fernandes-Alnemri T et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996; 93: 7464-7469.
29. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 β-converting enzyme. J Biol Chem 1994; 269: 30761-30764.
30. Tewari et al. Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81: 801-809.
31. Nicholson DW et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
32. Fernandes-Alnemri T, Litwack G, Alnemri ES. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 1995; 55: 2737-2742.
33. Orth K et al. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 1996; 271: 16443-16446.
34. Fernandes-Alnemri T et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 1995; 55: 6045-6052.
35. Kaufmann SH. Iunduction of endonucleolytic DNA damage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989; 49: 5870-5878.
36. Kaufmann SH et al. Specific proteolytic cleavage of poly-(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985.
37. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994; 269: 30757-30760.
38. Casciola-Rosen LA et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J Exp Med 1996; 183: 1957-1964.
39. Lazebnik YA et al. Studies of the lamin pioteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 1995; 92: 9042-9046.
40. Kayalar C. et al. Cleavage of actin by interleukin 1β-converting enzyme to reverse DNaseI inhibition. Proc Natl Acad Sci USA 1996; 93: 2234-2238.
41. Martin SJ et al. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 1995; 270: 6425-6428.
42. Brancolini C, Benedetti M, Schneider C. Microfilament reorganization during apoptosis: The role of Gas2, a possible substrate for ICE-like proteases. EMBO J 1995; 14: 5179-5190.
43. An B, Dou QP.. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 β-converting enzyme-like protease as candidate. Cancer Res 1996; 56: 438-442.
44. Emoto Y et al. Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J 1995; 14: 6148-6156.
45. Na SQ et al. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J Biol Chem 1996; 271: 11209-11213.
46. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 1994; 12: 991-1045.
47. Rosen A, Casciola-Rosen LA, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995; 181: 1557-1561.
48. Levine B et al. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 1993; 361: 739-742.
49. McCauliffe DP et al. Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen. J Clin Invest 1990; 85: 1379-1391.
50. Singh NK, Atreya CD, Nakhasi HL. Identification of calreticulin as a rubella virus RNA binding protein. Proc Natl Acad Sci USA 1994; 91: 12770-12774.
51. Nakhasi HL, Cao X, Roualt TA, Liu T. Specific binding of host cell proteins to the 3′-terminal stem-loop structure of rubella virus negative-strand RNA. J Virol 1991; 65: 5961-5967.
52. Kotzin BL. Systemic lupus erythematosus. Cell 1996; 85: 303-306.